Do multiple nuclear factor kappa B activation mechanisms explain its varied effects in the heart?

Rajesh Kumar1, Qian Chen Yong, Candice M Thomas

  • 1Division of Molecular Cardiology, College of Medicine, Texas A&M Health Science Center, Scott & White Healthcare, and Central Texas Veterans Health Care System, Temple, TX.

Ochsner Journal
|March 28, 2013
PubMed

Insights

Nuclear factor kappa B (NF-κB) plays a complex role in heart function, with its effects varying by mechanism and timing. Understanding these nuances is crucial for clarifying its impact on cardiac pathology.

Area of Science:

  • Cardiology
  • Molecular Biology
  • Biochemistry

Background:

  • Nuclear factor kappa B (NF-κB) is implicated in cardiac pathology, but its precise role remains debated.
  • NF-κB signaling is complex, involving multiple components and regulatory steps.
  • NF-κB integrates signals from pathways like the renin-angiotensin system (RAS) and cytokines, which modulate cardiac remodeling.

Purpose of the Study:

  • To review studies on NF-κB activation in the heart.
  • To elucidate the mechanisms of NF-κB in relation to RAS, inflammation, and diabetes.
  • To consolidate conflicting findings for a clearer understanding of cardiac NF-κB signaling.

Main Methods:

  • Literature review of studies investigating NF-κB in cardiac pathology.
  • Analysis of NF-κB mechanisms in the context of RAS, inflammation, and diabetes.
  • Synthesis of existing research to address contradictory conclusions.

Main Results:

  • NF-κB's effects on the heart are highly mechanism-specific.
  • NF-κB signaling exhibits cyclical patterns.
  • The timing of NF-κB activation and measurement is critical for interpreting its role.

Conclusions:

  • Clarifying NF-κB's dual role in cardiac pathophysiology requires understanding its mechanism-specific and temporal dynamics.
  • Future research should focus on the temporal changes in NF-κB signaling to resolve its complex functions.
  • A nuanced understanding of NF-κB is essential for addressing cardiac remodeling and pathology.
Abstract

Related Concept Videos

NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Co-activators and Co-repressors02:04

Co-activators and Co-repressors

Gene transcription is regulated by the synergistic action of several proteins that form a complex at a gene regulatory site. This is observed in eukaryotes, where the regulation of gene expression is a complex process. Regulatory proteins in eukaryotes can broadly be classified into two types – regulators that bind directly to specific DNA sequences and co-regulators that associate with regulatory proteins but cannot directly bind to the DNA. These co-regulators are further divided into...
General Transcription Factors01:30

General Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
Transcription Factors02:16

Transcription Factors

Tissue-specific transcription factors contribute to diverse cellular functions in mammals. For example, the gene for beta globin, a major component of hemoglobin, is present in all cells of the body. However, it is only expressed in red blood cells because the transcription factors that can bind to the promoter sequences of the beta globin gene are only expressed in these cells. Tissue-specific transcription factors also ensure that mutations in these factors may impair only the function of...
NF-kB-dependent Signaling Pathway02:26

NF-kB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...